University of Patras
Σχεδιασμός, σύνθεση και βιολογική αποτίμηση μη πεπτιδικών ανταγωνιστών του ΑΤ1 υποδοχέα της αγγειοτενσίνης ΙΙ με βάση το ουροκανικό οξύ, ως πιθανοί αντιυπερτασικοί παράγοντες
Abstract
dc:descriptionIn this thesis, the design and synthesis of nonpeptide mimetics of Angiotensin II (Ang II), a hypertension-inducing agent, which can bear chemical groups that simulate at least three of Ang II pharmacophores. The imidazole E-Urocanic Acid was used as the starting material, because an imidazole ring is the main structural characteristic of the many commercially available Sartans. However, aiming differentiation to them, alteration of the pharmacophore positions was attempted. Some sites of E-Urocanic Acid were suitably modified, resulting in the production of a variety of final analogs-potent Ang II AT1 receptor antagonists. At least one of the imidazole ring nitrogen atoms was substituted with a benzyl or biphenylyl aromatic system, on which a tetrazole moiety is always present. The carbohydrate chain of the 4-position of urocanic acid can be unsaturated or saturated and its terminal carboxyl group can be free or in the form of a methyl or (5-methyl-2-oxo-1,3-dioxol-4-yl) carboxylate. The last step of each synthetic route was the removal of the Trt-type protecting groups of the protected intermediates, which reveals their active pharmacophores. The final compounds were all afforded as bis trifluoroacetic acid salts. The Ang II AT1 receptor binding assay was performed for each of these analogs. This in vitro experiment demonstrated the affinity of the final compounds for the AT1 receptor and consequently their potency to act in an antagonistic manner.
Degree
thesis:*- Grantor dc:publisher
- University of Patras
- Year dc:date
- 2010
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Kelaidonis, Konstantinos
- Κελαϊδώνης, Κωνσταντίνος
Subjects
dc:subject × 18Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/29620